A new drug-releasing stent for coronary artery disease
Part of Heart & circulation clinical trials.
This trial is testing a new type of stent (a small tube that props open a narrowed heart artery) coated with a medicine called everolimus to keep the artery open. The study wants to see if the stent is safe and works well for people with coronary artery disease, which is narrowing of the heart's blood vessels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You need a diagnosis of coronary artery disease with one or more narrowed or blocked heart arteries that your doctor plans to treat with a stent (a small mesh tube to open the vessel).
- The narrowed section of the artery must be at least 70% blocked, and the artery size must be between 2.0 and 4.5 mm wide.
- The blockage length must be less than 48 mm, and it must be in a natural artery (not in a previously bypassed artery).
- You cannot be pregnant or breastfeeding, and you must have no severe heart failure (pumping function below 30%) or allergies to the stent materials or required medicines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new stent (a small mesh tube) to open narrowed heart arteries and improve blood flow. It may help people with multiple blocked arteries who are having a procedure to widen them.
This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.
This trial tests a new stent (a small mesh tube placed in your heart artery to keep it open) called MiStent II. The stent slowly releases a medicine to help prevent the artery from narrowing again. If you have coronary artery disease and need a stent, this study may help improve your treatment.
This trial tests a stent that slowly dissolves after opening a blocked heart artery, releasing a drug to prevent reclogging. It may help people with narrowing in one or two spots that are not too hard or twisted.
This trial is testing a special balloon coated with medication to treat newly formed blockages in the heart's arteries. The medication may help keep the artery open after the balloon opens it during a standard procedure.
This trial tests a new type of stent made from magnesium that slowly dissolves over time. It is for people who have a long blockage in a heart artery that has not been treated before and may be a good option for those who are stable and have not had a recent heart attack.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.